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Abstract
Little is known about dosage compensation in autosomal genes. Transcription-level compensation of deletions and other
loss-of-function mutations may be a mechanism of dominance of wild-type alleles, a ubiquitous phenomenon whose nature
has been a subject of a long debate. We measured gene expression in two isogenic Drosophila lines heterozygous for long
deletions and compared our results with previously published gene expression data in a line heterozygous for a long
duplication. We ﬁnd that a majority of genes are at least partially compensated at transcription, both for ½-fold dosage (in
heterozygotes for deletions) and for 1.5-fold dosage (in heterozygotes for a duplication). The degree of compensation does
not vary among functional classes of genes. Compensation for deletions is stronger for highly expressed genes. In contrast,
the degree of compensation for duplications is stronger for weakly expressed genes. Thus, partial transcriptional
compensation appears to be based on regulatory mechanisms that insure high transcription levels of some genes and low
transcription levels of other genes, instead of precise maintenance of a particular homeostatic expression level. Given the
ubiquity of transcriptional compensation, dominance of wild-type alleles may be at least partially caused by of the regulation
at transcription level.
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Introduction
In bisexual organisms with chromosomal sex determination,
sex-linked genes occur in different dosages in the two sexes,
and this dosage difference in genes not directly related to
sex determination is compensated by a variety mechanisms,
such as deactivation of one of X chromosomes in mamma-
lian females (Lyon 1988; Straub and Becker 2007) or higher
expression of X-linked genes in Drosophila males (Baker
et al. 1994; Stuckenholz et al. 1999; Gupta et al. 2006).
Muchlessisknownaboutautosomaldosagecompensation.
Gene-speciﬁcdataindicatethatautosomaldosagecompen-
sation may be a common phenomenon in Drosophila and
that it is likely to occur on the transcriptional level (Devlin
et al. 1982; Birchler et al. 1990). Broader evidence that
a broad spectrum of autosomal genes are under transcrip-
tional regulation compensating for aneuploidy comes from
transcriptome analysis of trisomies (FitzPatrick et al. 2002)
and cancer-associated aneuploidies (Tsafrir et al. 2006;
Williams et al. 2008) in human and mice and a variety of
aneuploid genotypes in yeast (Torres et al. 2007). Although
transcriptional level, as detected by microarrays, generally
followed the DNA dosage trend in these studies, two impor-
tant trends became apparent: at least some genes in aneu-
ploid regions are, in fact, transcribed at a nearly normal
diploid level and many misregulated genes are not located
in aneuploid regions (FitzPatrick et al. 2002; Tsafrir et al.
2006). In contrast to mammalian and yeast data, two recent
studies (Guptaet al.2006; Stenbergetal.2009; Zhang etal.
2009) indicated that autosomal dosage compensation is
a rule rather than exception in Drosophila (see below).
If autosomal transcriptional dosage compensation is in-
deed common in at least some organisms, three important
questions can be asked. First, do these mechanisms act
on gene-speciﬁc level or on the level of larger chromosomal
segments? Second, are these mechanisms capable of ﬁne-
tuned regulation of transcription level compensating for
both deﬁciencies and duplications or do they operate on
a more coarse scale, that is, assuring that genes with
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GBEhigh-demand products are expressed at a sufﬁciently high
level? Finally, can autosomal dosage compensation be the
fundamental basis of dominance?
Dominance is a pervasive although not a universal prop-
erty of genes. There are two aspects of dominance that
require explanation: 1) why do most genes exhibit complete
dominance of one of the alleles rather than additivity of the
action of two alleles (i.e., why is codominance a relatively
rare phenomenon), and 2) why is it the wild-type allele that
is usually dominant. Possible explanation of these factors
hasbeenthesubjectofperhapstheﬁercestdebatebetween
the founding fathers of modern synthesis. Fisher (1928)
proposed that dominance of the wild-type alleles is the re-
sult of selection on modiﬁer genes, which epistatically mask
the action of the mutant allele in a heterozygote. By neces-
sity such evolution can only occur in the heterozygous sub-
population. This idea was met with criticism by cofounders
of the modern synthesis (Wright 1934; Haldane 1939). In-
stead, Wright suggested that dominance is an inherent
property of the physiological systems, perhaps evolved
through selection to provide a safety margin in the action
of a single functional copy of a gene, which would allow
to accommodate for environmental ﬂuctuations and for
the lack of activity of the other gene. Such selection would
act on the entire population, not on heterozygotes only, and
is therefore much more powerful.
A variety of studies during last 30 years provided strong
evidence in favor of the physiological theory of dominance.
In particular, the metabolic control theory (Kacser and Burns
1981) implies that enzymes functioning in metabolic path-
ways are bound to exhibit a diminishing return relationship
between activity of an individual enzyme and the ﬂux of
metabolites through the whole pathway, which ultimately
determines the phenotype. Thus, 2-fold change in protein
titer (as in a heterozygote for a loss-of-function mutation)
is usually negligible in terms of the resulting phenotype. This
idea was supported by negative correlation between the
strength ofa mutantallele and its dominance(Charlesworth
1979; Crow 1979; Crow and Simmons 1983; Phadnis and
Fry 2005). Further support to the physiological dominance
theory came from the observation that dominance is prev-
alent in organisms, which spend much of their life cycle in
haploid phase, such as in Chlamydomonas (Orr 1991) or ﬁs-
sion yeast (Baek et al. 2008). Finally, loss-of-function muta-
tions are more likely to be fully recessive in enzyme-coding
genes than in genes coding for structural or regulatory pro-
teins (Fisher and Scambler 1994; Veitia 2002; Kondrashov
andKoonin2004)andforproteinsthatarelesslikelytoform
protein complexes (Papp et al. 2003). Due to these ﬁndings,
the physiological mechanisms behind dosage compensa-
tions are thought to be acting primarily on the protein level.
On the other hand, dosage compensation may as well
occur at the lever of transcription, resulting in a mechanism
of dominance independent from the protein function. Eu-
karyotic transcriptional machinery is equipped with a stun-
ning variety of mechanisms enabling ﬁne-tuned regulation
of transcription (Lee et al. 2002). Such mechanisms often
incorporate negative feedbacks allowing adjustment of
transcription level to match the environmental ﬂuctuations
or tissue-speciﬁc developmental needs; these feedbacks
may as well provide compensation for a loss-of-function
mutation in one of the alleles. On the other hand, one
can hypothesize that, in many genes, the regulation of gene
expression may be a lot less sophisticated and lacking ﬁne-
tuned gene-speciﬁc homeostasis mechanisms. In fact, the
number of transcription factors present in the genome is
constrained by the limits set by coding theory: unlimited in-
crease of the number of transcription factors capable of rec-
ognizing speciﬁc nucleotide sequences would lead to the
increase of misrecognition errors (Itzkovitz et al. 2006). In-
stead,theremay begenes codingfor highdemandproteins,
which are constitutively transcribed at a high rate, and
genes coding for low demand proteins, whose transcription
is maintained at low level. If this is true, one would expect
that transcriptional dosage compensation to be widespread
and to correlate with the overall gene expression level. In-
deed, the pervasive nature of autosomal transcriptional
compensation has been recently demonstrated in Drosoph-
ila (Gupta et al. 2006; Stenberg et al. 2009). In particular,
Stenbergetal.(2009)reportthatthedegreeofcompensation
is different in genes with different degree of tissue speciﬁcity
of expression: ubiquitously expressed genes are stronger
compensated for deﬁciencies and less effectively for a dupli-
cation than tissue-speciﬁc ones. Stenberg et al. (2009) also
suggest that there is no correlation between the degree of
compensation and overall expression level. Here, we test
these results using three sets of Drosophila genes. We mea-
sured the level of gene expression in two isogenic deletional
lines using oligonucleotide microarrays and compared our
results with published data on transcriptional compensation
in heterozygotes for a duplication (Gupta et al. 2006).
Materials and Methods
Two DrosDel (Ryder et al. 2007) Drosophila melanogaster
isogenic lines, Df(3L)ED4475 and Df(3L)ED4543, heterozy-
gous for long deletions on 3L chromosomal branch both
maintained against the TM6C balancer, were used for mi-
croarray experiment. Twenty-ﬁve adult ﬂies 2–5 days after
eclosion were frozen in liquid nitrogen and used for RNA
extractionbyTrizol method(Invitrogen)in 12replicatesfrom
each line. Samples were reverse transcribed, labeled, and
hybridized to two-color 14k oligonucleotide microarrays
by Canadian Drosophila Microarray Centre (Missassauga,
Ontario, Canada; Neal et al. 2003). The two lines, which
serve as controls for each other, were alternated between
Cy3 and Cy5 dyes to minimize possible channel bias.
Fluorescence intensity data (background intensity
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tute 2007). The data are available at Gene Expression Omni-
bus (GEO) (Edgar et al. 2002; http://www.ncbi.nlm.nih.gov/
gds; accession number GSE14799).
Data were ANOVA-normalized to eliminate the effects
of arrays and channels, mean intensity of ﬂuorescence
for hemizygous and diploid line calculated for each gene
and the ratio of the intensity in the line with the deletion
to that in the control line (R) analyzed. For a comparison
with Gupta et al. (2006), in which raw data are available
and to avoid possible expression level-dependent bias in
expression ratios, the correlation between expression ratio
and mean expression level was also analyzed without any
normalization; the results are virtually identical. Line
ED4475 had slightly but statistically signiﬁcantly higher
ﬂuorescence across the genome (ED4475: ED4543 5
1.017 for diploid genes), and therefore, the ratio was ad-
justed by this factor. This adjustment had no effect on any
of the ﬁndings reported. Presence or absence of expression
for each gene was evaluated by comparison of average
ﬂuorescence across all arrays with the internal blank (Au-
toBlank) intensities and genes with intensities signiﬁcantly
(P , 0.05) above the AutoBlank level were considered de-
tectable. The distribution of R in hemizygous genes was
analyzed by maximum likelihood as a superposition of
two normal distributions one with the mean of 0.5 (un-
compensated genes), the other (partially compensated
genes)withunknownmean;thisunknownmean,standard
deviations of both distributions and the frequency of un-
compensated genes were simultaneously optimized.
In order to verify that the observed expression ratios in
deletion lines are not an artifact of inherent microarray
noise, we performed a neural network-based analysis of
the distribution of expression ratios along the chromosome.
A neural network consisting of three nodes in one hidden
layer and implemented within JMP Genomics package
(SAS Institute 2007) was provided the input data in the form
of expression ratio for each gene with detectable expression
along with the expression ratios of this gene’s ﬁve nearest
neighbors on each side (again, using only gene with detect-
able expression). Thenetworkwasthen trainedtorecognize
each deletion using the data on the other deletion as the
training set. The network recognized genes within deletions
with 4.4% of false negatives (almost all on the deletion
breakpoints) and 9.75% false positives (ﬁg. 1). More than
half of the false positives were present in runs of more than
three adjacent genes and may represent actual unknown
short deletions present in the DrosDel lines we used. We
conclude, therefore, that our data contain a sufﬁciently
strongsignal to allow us the comparison of expression ratios
between hemizygous and diploid genes.
Following Stenberg et al. (2009) approach, to compare
ubiquitously expressed genes to tissue-speciﬁc genes, genes
were classiﬁed as ‘‘ubiquitous’’ if they had expression value
of at least 6 in all 26 adult and larval tissues present in the
FlyAtlas database (Chintapalli et al. 2007).
Gupta et al. (2006) data were obtained from GEO (Edgar
et al. 2002), accession numbers GSM37444, GSM37445,
GSM37447, GSM37448, GSM77751, and GSM77752.
These data contain expression levels in heterozygotes for
a long duplication Dp(2;2)Cam3 relative to heterozygotes
for a deletion Df(2L)JH located within the duplication.
Thus, genes located within the duplication but outside of
the deletion are compared with the diploid wild type
(1.5-fold dosage), whereas genes located within the dele-
tion are compared in lines with 3-fold gene dosage. There
are 289 genes (2.1% of the genome) in the Dp(2;2)Cam3
duplication, 59 of which (0.4% of the genome) lay within
FIG.1 . —Sliding average (±5 genes) of expression ratio along 3L chromosome branch. Gray line: diploid genes (wild type:wild type); red line: genes
in deletions (Deletion:wild type). Thick red bars at log2R 5  0.5 indicate genes identiﬁed as hemizygous by a neural network prediction.
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traction, microarray hybridization and scanning, and data
handling details.
Results
Deletions ED4475 and ED4543 contain 119 and 65 genes,
respectively, comprising about 1.3% of the genome. Of
these 184 genes all 184 demonstrated transcription level re-
sulting in higher than background ﬂuorescence, however, in
only 69 (0.5% of the genome) the average ﬂuorescence
across all arrays was signiﬁcantly (P , 0.05) above the Au-
toBlank level. The distribution of expression ratios in genes
with detectable expression along the chromosomal branch
3L, along with the neural network identiﬁcation of hemizy-
gous regions is presented on ﬁgure 1. Further statistical
analysis, except the distribution shown on ﬁg. 2A, is done
only on genes with detectable expression. The distribution
of ratio of mean ﬂuorescence intensities (log2R) of hemizy-
gous genes (i.e., genes within the deletions) is signiﬁcantly
different from that of the genes outside of the deletions
(P , 10
 12, ﬁg. 2A). It is shifted to the left (lower expression
of hemizygous genes) with the modal class at log2R 5  0.1
(R 5 0.93) and with a distinct shoulder at log2R 5  1
(the value expected in case of no transcriptional compensa-
tion). The frequency of observations within  1.32 to  0.74
range (corresponding to the range of ratios 0.4–0.6)
among hemizygous is signiﬁcantly higher than among
diploid genes (v
2 5 20.9, P , 0.0001). The distribution
of log2R differed somewhat between the two deletion lines
(P , 0.05) with the secondary mode around  1 more
pronounced in line ED4543 (ﬁg. 1), indicating that the fre-
quency of noncompensated genes may differ across chro-
mosomal regions. The distribution of log2R signiﬁcantly
deviated from normal in both deletion lines (Shapiro–Wilk
test, P , 0.004). Assuming a contaminated normal distribu-
tion (i.e., a distribution, in which the majority of observa-
tions is from a speciﬁed normal distribution, but a small
proportion is from a normal distribution with a different
mean and/or variance) and optimizing all parameters (both
means, both variances, and the degree of contamination),
the maximal likelihood estimate of the frequency of uncom-
pensated genes F0.5 was 0.05. Values of F0.5 exceeding 0.25
and 0.35 can beexcluded with signiﬁcance level of0.05 and
0.01, respectively. Thus, majority of genes within the two
deletions exhibit at least partial compensation at the stage
of transcription.
A similar result is apparent from the data from Gupta
et al. (2006; ﬁg. 2B). The distribution of the ratio of expres-
sion intensity in heterozygotes for duplication relative to
wild type and heterozygotes for duplication relative to het-
erozygotes for a deletion are signiﬁcantly higher than the
control (expression ratios of genes outside of the aberra-
tions; P , 10
 12) but with modes close to 0, indicating
nearly complete dosage compensation in many genes
and relatively few genes with no dosage compensation at
all. In both studies, the degree of dosage compensation ap-
pears to be independent from the molecular function cate-
gory to which genes belong (ﬁg. 3).
There was, as predicted, a positive correlation between
expression ratio (log2R) and overall expression level (log2M).
For heterozygotes, for deletions, the regression (ﬁg. 4A;
log2R 5  0.77 þ 0.077   log2M; P , 0.007; P , 0.02 with
the uppermost outlier point removed) suggests that genes
with barely detectable expression are nearly noncompen-
sated (log2R 5  1), whereas genes with highest observed
expressionlevel approach full compensation(log2R50). For
heterozygotes, for a duplicationversus diploid wild type,the
regression (ﬁg. 4B; log2R 5  0.77 þ 0.14   log2M; P ,
0.0001) suggests that there is a nearly complete compensa-
tion of low expression genes (log2R 5 0), whereas highly
expressed genes demonstrate little dosage compensation
(log2R 5 log2(1.5) 5 0.58). The regression of expression
ratio in heterozygotes for a duplication to that is heterozy-
gotes for a deletion (3-fold dosage difference) over overall
expression level is also positive (ﬁg. 4B; log2R 5  1.41 þ
0.25   log2M; P , 0.0008). The corresponding regression
for genes outside of the aberrations is nearly horizontal for
bothdatasets,suggestingthattheobservedcorrelationsare
not a product of a bias in the expression data. It should be
noted that this result is identical for both normalized and
nonnormalized data. The observed correlations are also
not artifacts of data fanning. For example, for deletions,
expression ratios for genes with lower expression are ex-
pected tend to be located below the log2R 5 0 line simply
forthereasonofbeingunderexpressedin hemizygousstate,
whereas expression ratios for highly expressed genes, if not
affected by mean expression, would be expected to cluster
around log2R 5  1, not log2R 5 0 as are points correspond-
ing to diploid genes.
Figure 5 shows the relationship between the degree of
tissue speciﬁcity of expression and degree of compensation
in two deletions in this study (A) and in a duplication (Gupta
et al. 2006; B). In one of the deletions, ED4475 (partly over-
lapping with the deletion used in Stenberg et al. 2009),
ubiquitously expressed genes are less strongly compensated
than tissue-speciﬁc genes (P , 0.003), but in the other de-
letion, ED4542, the difference is not signiﬁcant. Likewise,
for the duplication, transcriptional compensation of ubiqui-
tously expressed genes is weaker than that of tissue-speciﬁc
genes, in a reversal of the pattern observed on ﬁgure 3B in
Stenberg et al. (2009).
Discussion
Our data conﬁrm the recently observed phenomenon of
widespread transcriptional compensation of genes located
in haploid and triploid areas in Drosophila lines with
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cently reported in mammals (Williams et al. 2008) and yeast
(Torres et al. 2007). This conclusion is based on the compar-
ison of Aberration:wild type expression ratios to diploid
expression ratios and is, therefore, dependent on the as-
sumption that chromosomal aberrations as such have no
FIG.2 . —Distribution of logarithms of expression ratios. (A): this study. Deletion:wild type (red) and wild type:wild type (green). (B): Gupta et al.
(2006) data. Duplication:wild type (red), Duplication:Deletion (gray), and wild type:wild type (green).
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mind, we also demonstrate that the degree of such com-
pensation does not depend on the molecular function of
the coded protein. Stenberg et al. (2009) reported that
Aberration:wild type expression ratios are distributed nor-
mally, indicating a universal (or at least chromosome wide
or segment wide) rather than gene-speciﬁc compensatory
mechanism. Here we demonstrate that for in both deletions
studied the distribution of Deletion:wild type ratios was sig-
niﬁcantly deviant from normal, with a strong suggestion of
a shoulder around log2R 5  1, which suggest that some
genes are stronger compensated than others, perhaps
through the action of at least some gene-speciﬁc regulatory
mechanisms. On the other hand, higher level of transcrip-
tional compensation in tissue-speciﬁc genes than in ubiqui-
tously expressed genes (see below) was observed for one
deletion but not for the other, suggesting that some chro-
mosomal segment-speciﬁc regulation may be taking place.
Furthermore,in contrast toStenberg etal.(2009), weob-
serve a correlation between the degree of compensation
andtheoverallexpressionlevelofagene.Geneswithhigher
expression level are more likely to be compensated for a de-
letion but less likely to be compensated for a duplication. A
positive correlation between transcriptional compensation
of a deletion and overall expression level (ﬁg. 4A) can be
explained by the existence of genes, which are constantly
expressed at the highest possible level, limited by gene-
unspeciﬁc factor such as the availability of RNA polymerase
complexes or individual transcription factors. However, this
explanation is incompatible with the observed positive
correlation between compensation for duplication and
expression level (ﬁg. 4B): transcriptional limitation of highly
expressed genes would result in this correlation having
a negative not positive sign. We hypothesize that this ﬁnd-
ing indicates that highly expressed genes are equipped with
a regulatory feedback mechanism more efﬁcient in prevent-
ing underexpression than in preventing overexpression. In
contrast, genes with low overall expression are more efﬁ-
ciently regulated to prevent overexpression in case of an
overdose than to prevent underexpression in case of half
the normal dosage.
Wehypothesizethattherelationshipbetweenthedegree
of transcriptional dosage compensation and overall gene
expression may be widespread. Although Stenberg et al.
(2009) reported such relationship for only 1 comparison
out of 4, a careful examination of their ﬁgure S4A, suggests
that at least one other comparison may be approaching sig-
niﬁcance, demonstrating the same pattern we observed in
this study:highly expressedgenes arestrongly compensated
for the deﬁciency, perhaps with a hint of a nonmonotonic
relationship(seealsoﬁg.S2inStenbergetal.2009).Itmight
be suggested that the reason why in Stenberg et al. (2009)
did not observe this correlation, despite using very similar
deletion lines, is that in this study we used a more stringent
criterion to exclude genes with expression rate near or be-
low detection level (and, therefore, meaningless expression
ratios) by excluding genes with transcript signal not statis-
tically different from the AutoBlank signal across arrays.
Meanwhile, in Stenberg et al. (2009) study, an arbitrary cut-
offwasused,possiblyleavinginsomegeneswithlowsignal-
to-noise ratio. This would account both for the lack of
a signiﬁcant correlation with the expression level and for
the apparent nonmonotonic relationship between expres-
sion ratio in deﬁciencies and expression level (ﬁg. 4A and
C in Stenberg et al. 2009).
We also partly conﬁrm the ﬁnding of Stenberg et al.
(2009) that ubiquitous genes are less effectively compen-
sated for the dosage deﬁciency. The fact that this
FIG.3 . —Expression ratio in heterozygotes for deﬁciencies relative to wild type (dark bars, this study), heterozygotes for a duplication relative to
wild type (white bars, Gupta et al. 2006), and in heterozygotes for duplication relative to heterozygotes for a deﬁciency (gray bars, Gupta et al.
2006), by molecular function. Error bars are standard errors reﬂecting variation among genes within molecular function category. One-way analysis of
variance results for the three data sets were: F 5 0.64; P . 0.69; F 5 0.48, P . 0.87, and F 5 1.06, P . 0.4034 for this study, Gupta et al. (2006),
duplication versus wild type and Gupta et al. (2006), duplication versus deletion, respectively.
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corroborates Stenberg et al. (2009) idea that such compen-
satory mechanisms may be chromosome region speciﬁc or
chromosomal region speciﬁc. Observe that the correlation
with gene expression level is not confounded with this re-
sult: ubiquitously expressed genes tend to have a higher ex-
pressionlevel(simplyduetothewaytheyaredeﬁnedforthis
analysis), so if the correlations with expression level were ar-
tifacts of confounding with the ubiquitousness of gene ex-
pression, it would have been expected to the opposite of
what is actually observed. Stenberg et al. (2009) suggest
that transcription of ubiquitously expressed genes tend to
be limited by copy number. Although consistent with the
patternsobservedfordeletionsinthisstudyandbyStenberg
et al. (2009), this explanation is inconsistent with higher de-
gree of compensation of ubiquitously expressed genes: if
these genes were universally copy number limited, one
would expect the transcription level to be directly propor-
tional to the number of copies of the gene.
Rather,wehypothesizethatthe observedpatterns canbe
explained by the existence of a continuum of genes with re-
spect to most general types of regulatory mechanisms,
genes on one end of the distribution being compensated
moreefﬁciently forunderexpressionthan foroverexpression
and with the pattern reversed on the opposite end of the
continuum. The former types of genes tend to: 1) have high
overall expression or be expressed in a tissue-speciﬁc man-
ner, 2) demonstrate a stronger dosage compensation for
a deﬁciency, and 3) demonstrate little dosage compensation
for duplication. Genes of the second type tend to have low
overall expression or be expressed ubiquitously, demon-
strate little compensation for deﬁciency and greater com-
pensation for duplication. At present it is impossible to
differentiate between two possibilities: 1) highly expressed
genes are equipped with a regulatory mechanism more ef-
ﬁcientlypreventingunderexpressioninordertomaintainthe
required high level of expression and 2) a regulatory mech-
anism more efﬁcient in preventing underexpression than
overexpression causes the cognate gene to have a higher
than average baseline expression level. One consideration
speaks in favor of the former hypothesis: highly expressed
genes are known to evolve slower (Pa ´l et al. 2001;
Drummond and Wilke 2008), which indicates that essential
or household genes are overrepresented among genes with
high expression level. One might speculate that household
genes are more likely than nonessential genes to evolve
a regulatory mechanism maintaining a necessary minimal
level of transcription but morepermitting of overexpression.
Likewise, it remains unknown whether the observed
compensation patterns are a manifestation of some gen-
eralregulatory mechanisms (whether gene-speciﬁc or
chromosome-wide) capable of detecting copy number
imbalance and predating the individual aberrations, or
the result of a recent and fast adaptation to compensate
for the aberration, which occurred in these particular lines
since the introduction of the chromosomal abnormality.
Some of the lines used in these studies (such as Df(2L)JH
in Gupta et al. 2006; Stenberg et al. 2009) are fairly old
and had an ample opportunity to evolve; others, as DrosDel
lines in Stenberg et al. (2009) and this study are younger but
have also been maintained in a balanced hemizygous state
for some time.
One observation, namely the comparison of expression
rate in heterozygotes for a duplication to that in heterozy-
gotes for a deletion in Gupta et al. (2006) experiment, is
puzzling. If transcriptional compensation of genes in dele-
tion Df(2L)JH is characterized by the same patters observed
deletions in our experiment, then the expected correlation
between expression ratio Duplication:Deletion and overall
gene expression should be negative. Yet, this regression
has a positive slope, in fact, higher than the regression of
FIG.4 . —Correlation between logarithm of mean expression level
and logarithm of Aberration: wild type expression ratio. (A): this study
(red circles: Deletion:wild type). (B): Gupta et al. (2006) data (orange
circles: Duplication: wild type; green circles: Duplication:Deletion). Small
circles are control (diploid) genes on both A and B. log2R 5
0 corresponds to full dosage compensation.
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our data is region or chromosome speciﬁc, or the deletion
Df(2L)JH (which contains only 59 genes) happens to be
enriched with genes fully compensated despite their low
expression level.
High degree of transcriptional compensation in heterozy-
gotes for a deletion suggests that recessivity of most loss-of-
function mutations in Drosophila can be explained by
transcriptional compensation. This implies that relatively
rare dominant mutant alleles either are not compensated
at transcription or are gain-of-function mutations. There
are only three genes with known dominant mutant alleles
located within studied deletions (Dichaete, frizzled, and
breathless), and none of them show detectable expression,
so we cannot test the hypothesis that these genes are less
likely to be compensated than genes with fully recessive
mutations. It might be noted, however, that the line
ED4543, which is hemizygous for Dichaete, does not exhibit
the dominant phenotype of classic Dichaete alleles
(extended and elevated wings), indicating that the classic
alleles may be of gain-of-function type.
We hypothesize that dominance of the wild-type allele
caused by transcription-level compensation is a by-product
of the regulatory mechanisms whose purpose is to maintain
the expression level to meet changing environmental or de-
velopmental conditions rather than a direct result of selec-
tion to compensate for mutant alleles. This hypothesis is
consistent with the theoretical prediction that selection to
compensate for mutations is weak, whereas selection to
maintain the optimal gene expression is strong (Hurst and
Randerson 2000) and with the observation that mammalian
genes possess abundant variation for such optimization
(Rockman and Wray 2002). It is also consistent with the
increased frequency of codominance of deleterious alleles
observed in genes whose products are involved in protein–
protein interactions (Papp et al. 2003). Such interactions re-
quire a balance between expression levels of all genes in
a group of interacting genes, which imposes constraints
on the evolution of regulation of individual genes, resulting
in lower opportunity for transcriptional compensation.
Because highly expressed genes demonstrate a more
complete compensation for deletions, we predict that tran-
scriptional compensation-baseddominanceofthewild-type
alleles should be more common in highly expressed genes,
whereas dominant mutations are more likely in genes with
low overall expression. Moreover, we can hypothesize that
transcriptional-level dominance can be of two types: in
genes with high expression loss-of-function mutations are
compensated at transcription, whereas in genes with low
expression high levels of gene products are simply not nec-
essary, that is, haploinsufﬁciency is unlikely.
We also found that, unlike compensation on the protein
level, transcriptional compensation appears to be indepen-
dent of protein function. We do not see any evidence of
greater transcriptional compensation of enzyme-coding
genes than regulatory genes coding for transcription factors
and nucleic acid-binding proteins. It is hard to imagine that
all genes for transcription factors are regulated at transcrip-
tion, because it implies an endless pyramid of transcription
factors for transcription factors and leads to low ﬁdelity of
regulation (Itzkovitz et al. 2006). In addition, not every tran-
scription regulation mechanism will automatically compen-
sate for mutant alleles. For this to occur, the regulatory
mechanismmustbebasedonanegativefeedbackdetecting
abundance or activity or of the gene product. Positive reg-
ulatory mechanisms, for example those, which detect a par-
ticular environmental variable, independent from the gene
product will not result in transcriptional compensation of
mutations. It should be therefore possible to test the hy-
pothesis that transcriptional compensation is a by-product
ofevolutionofnegativefeedbackregulationoftranscription
by measuring transcription level in genes known to respond
to environmental cues and in genes known to respond to
abundanceoractivityoftheirownproducts.Wepredictthat
FIG.5 . —Strength of transcriptional compensation in tissue-speciﬁc and ubiquitously expressed genes in two deletions (A, this study) and in
a duplication (B, Gupta et al. 2006).
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pensation of mutations than the second one.
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